Royal Orchid Hotels Limited
ROHLTD · NSE · Consumer Cyclical
With a 20% margin of safety, our buy-below price is ₹217.74.
Piotroski F-score 3/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%12.8%
- ✕Low debt (D/E < 0.5)2.33x
- ✓Positive free cash flow
- ✓Revenue growth > 10%31%
- ✕Earnings growing-39%
- ✕Net margin ≥ 10%8.4%
- ✕Current ratio > 1.51.22
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✕Altman Z in safe zoneZ 1.04
- ✕Piotroski ≥ 73/9
1-year price
EOD · 2026-06-16Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Quarterly results
Annual financials
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
SWOT snapshot
Weaknesses
- •High debt relative to equity.
- •Price below its 200-day moving average (downtrend).
- •Weak Piotroski score (3/9).
Opportunities
- •Revenue growing (31% YoY).
- •Well off its 52-week high — possible mean-reversion.
Threats
- •Earnings contracting year on year.
- •Balance-sheet stress — Altman Z 1.04.
About Royal Orchid Hotels Limited
Royal Orchid Hotels Limited, together with its subsidiaries, operates and manages hotels and resorts for business and leisure travelers in India and Tanzania. The company operates 5-star and 4-star hotels and resorts under the Regenta, Hotel Royal Orchid, Royal Orchid Suits, Regenta Central, Regenta Resort, Royal Orchid Resort, Royal Orchid Central, Regenta Place, Regenta Z, and Regenta Inn. It also offers restaurant services
More in Consumer Cyclical
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.